Review Article | Â | |||||||||||||||||||||||||||||
J Microbiol Infect Dis. 2013; 3(3): 147-149 Thyroid disorders associated with Hepatitis C or interferon based therapies Şener Barut, ÖzgÜr GÜnal.
|
How to Cite this Article |
Pubmed Style Barut Å, Gunal O. Thyroid disorders associated with Hepatitis C or interferon based therapies. J Microbiol Infect Dis. 2013; 3(3): 147-149 . doi:10.5799/jmid2013.03.0099 Web Style Barut Å, Gunal O. Thyroid disorders associated with Hepatitis C or interferon based therapies. https://www.jmidonline.org/?mno=302657393 [Access: January 09, 2025]. doi:10.5799/jmid2013.03.0099 AMA (American Medical Association) Style Barut Å, Gunal O. Thyroid disorders associated with Hepatitis C or interferon based therapies. J Microbiol Infect Dis. 2013; 3(3): 147-149 . doi:10.5799/jmid2013.03.0099 Vancouver/ICMJE Style Barut Å, Gunal O. Thyroid disorders associated with Hepatitis C or interferon based therapies. J Microbiol Infect Dis. (2013), [cited January 09, 2025]; 3(3): 147-149 . doi:10.5799/jmid2013.03.0099 Harvard Style Barut, Å. & Gunal, . O. (2013) Thyroid disorders associated with Hepatitis C or interferon based therapies. J Microbiol Infect Dis, 3 (3), 147-149 . doi:10.5799/jmid2013.03.0099 Turabian Style Barut, Åžener, and Ozgur Gunal. 2013. Thyroid disorders associated with Hepatitis C or interferon based therapies. Journal of Microbiology and Infectious Diseases, 3 (3), 147-149 . doi:10.5799/jmid2013.03.0099 Chicago Style Barut, Åžener, and Ozgur Gunal. "Thyroid disorders associated with Hepatitis C or interferon based therapies." Journal of Microbiology and Infectious Diseases 3 (2013), 147-149 . doi:10.5799/jmid2013.03.0099 MLA (The Modern Language Association) Style Barut, Åžener, and Ozgur Gunal. "Thyroid disorders associated with Hepatitis C or interferon based therapies." Journal of Microbiology and Infectious Diseases 3.3 (2013), 147-149 . Print. doi:10.5799/jmid2013.03.0099 APA (American Psychological Association) Style Barut, Å. & Gunal, . O. (2013) Thyroid disorders associated with Hepatitis C or interferon based therapies. Journal of Microbiology and Infectious Diseases, 3 (3), 147-149 . doi:10.5799/jmid2013.03.0099 |